Previous studies showed that CCL5 was exerted by binding to CCR5 and could promote the growth, migration and invasiveness of pancreatic cancer or HCC cells in vitro (Mohs et al., 2017; Singh et al., 2018; Xue et al., 2021). Here, CCL5 is linked to hepatocellular carcinoma.